Does the Macroduct® collection system reliably define sweat chloride concentration in subjects with intermediate results?

Clinical Biochemistry

Volumn 42, Issue 12, 2009, Pages 1260-1264

  Rose, J B ^a   Ellis, L ^a   John, B ^b   Martin, S ^a   Gonska, T ^a,b,d   Solomon, M ^b,d   Tullis, E ^c,d   Corey, M ^a,b,d   Adeli, K ^a,b,d   Durie, P R ^a,b,d  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cystic Fibrosis; Sweat chloride; Sweat testing

Indexed keywords

CHLORIDE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC VALUE; FEMALE; HETEROZYGOTE; HUMAN; INTERMETHOD COMPARISON; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PANCREAS INSUFFICIENCY; PANCREATITIS; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; SWEAT TEST; VAS DEFERENS; CHEMISTRY; DIAGNOSIS, MEASUREMENT AND ANALYSIS; EVALUATION; INSTRUMENTATION; LABORATORY DIAGNOSIS; METHODOLOGY; MIDDLE AGED; PANCREAS EXOCRINE INSUFFICIENCY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SWEAT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHLORIDES; CYSTIC FIBROSIS; EXOCRINE PANCREATIC INSUFFICIENCY; FEMALE; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; SWEAT; YOUNG ADULT;

EID: 67650713588     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.05.001     Document Type: Article

References (20)

1. Welsh M.J., Ramsey B.W., Accurso F., and Cutting G.R. Cystic fibrosis. In: Scriver C., Beaudet A., Sly W.S., Valle D., Childs B., Kinzler K.W., and Vogelstein B. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York 5121-5187
2. Quinton P. Chloride impermeability in cystic fibrosis. Nature 301 (1983) 421-422
3. Di Sant Agnese P., Darling R., Perera G., and Shea E. Sweat electrolyte disturbances associated with childhood pancreatic disease. Am. J. Med. 15 (1953) 777-784
4. Gibson L., and Cooke E. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 23 (1959) 545-549
5. Gibson L., di Sant Agnese P., and Schwachman H. Procedure for the Quantitative Iontophoretic Sweat Test for Cystic Fibrosis (1985), Cystic Fibrosis Foundation, Bethesda (MD)
6. Farrell P.M., Rosenstein B.J., White T.B., et al. Cystic Fibrosis Foundation. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J. Pediatr. 153 2 (2008) S4-S14
7. LeGrys V.A., Burritt M.F., Gibson L.E., Hammond K.B., Kraft K., and Rosenstein B.J. Sweat Testing: Sample Collection and Quantitative Analysis: Approved Guideline (1994), National Committee for Clinical Laboratory Standards, Villanova (PA) Publication No C34-A2
8. Hammond K.B., Turcios N.L., and Gibson L.E. Clinical evaluation of the Macroduct sweat collection system and conductivity analyzer in the diagnosis of cystic fibrosis. J. Pediatr. 124 2 (1994) 255-260
9. Mastella G., Di Cesare G., Borruso A., et al. Reliability of sweat-testing by the Macroduct collection method combined with conductivity analysis in comparison with the classic Gibson and Cooke technique. Acta Paediatr. 89 8 (2000) 933-937
10. Bishop M.D., Freedman S.D., Zielenski J., et al. The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis. Hum. Genet. 118 3-4 (2005) 372-381
11. Wilschanski M., Dupuis A., Ellis L., et al. Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials. Am. J. Respir. Crit. Care Med. 174 (2006) 787-794
12. Rosenstein B.J. Nonclassic cystic fibrosis: a clinical conundrum. Pediatr. Pulmonol. 36 (2003) 10-12
13. Knowles M.R., and Durie P.R. What is cystic fibrosis?. N. Engl. J. Med. 347 (2002) 439-442
14. Highsmith W.E., Burch L.H., Zhou Z., et al. A novel mutation in the CF gene in patients with pulmonary disease but normal sweat chloride concentrations. N. Engl. J. Med. 331 (1994) 974-980
15. Mackay R.J., Florkowski C.M., George P.M., Sies C.W., and Woods S. Uncertainty of sweat chloride testing: does the right hand know what the left hand is doing?. Ann. Clin. Biochem. 45 Pt 6 (2008) 535-538
16. Soultan Z.N., Foster M.M., Newman N.B., and Anbar R.D. Sweat chloride testing in infants identified as heterozygote carriers by newborn screening. J. Pediatr. 153 6 (2008) 857-859
17. Clinical Laboratory Standards Institute formerly National Committee for Clinical Laboratory Standards, Sweat Testing: Sample Collection and Quantitative Analysis: Approved Guideline: National Committee for Clinical Laboratory Standards, Wayne, PA 2000, NCCLS Document C34-A2.
18. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i (1986) 307-310
19. Mishra A., Greaves R., Smith K., et al. Diagnosis of cystic fibrosis by sweat testing: age-specific reference intervals. J. Pediatr. 153 6 (2008) 758-763
20. Beauchamp M., Grey V., and Lands L.C. Sweat collection for testing in Canadian Cystic Fibrosis Centers, is it optimal?. Clin. Biochem. 38 (2005) 934-937